Pathologic Predictors of Microsatellite Instability in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Identification of microsatellite unstable (MSI-H) colorectal cancers (CRCs) is important not only for the identification of hereditary nonpolyposis colorectal cancer syndrome but also because MSI-H CRCs have a better prognosis and may respond differently to 5-fluorouracil-based chemotherapy. We present 2 nearly equivalent logistic regression models for clinical use that predict microsatellite instability based on the review of 1649 CRCs from patients of all ages collected in a population-based case control study in northern Israel. One hundred ninety-eight of these 1649 tumors demonstrated a high degree of microsatellite instability (12%). Multivariate analysis found that >2 tumor-infiltrating lymphocyte (TIL) cells per high-powered field, the lack of dirty necrosis, the presence of a Crohn-like reaction, right-sided location, any mucinous differentiation (mucinous or focally mucinous) and well or poor differentiation, and age less than 50 were all independent predictors of MSI-H. We developed 2 logistic regression models that differ only by the statistical approach used to analyze the number of TIL cells per high-powered field, where the slightly more accurate (and complex) model uses the log of the total number of TIL cells. The simpler clinical model uses a cut-off of 2>TIL cells per high-powered field. The accuracy of both models is high, with an 85.4% versus 85.0% probability of correctly classifying tumors as MSI-H. By employing the simpler model, pathologists can predict the likelihood of microsatellite instability by compiling the MSI probability score (Table 4 and Fig. 1) from simple histologic and clinical data available during sign-out. Our model shows that approximately 43% of CRCs have a MSI probability score of 1 or less and hence have little likelihood (<3%) of being MSI-H. Although this model is not perfect in predicting microsatellite instability, its use could improve the efficiency of expensive diagnostic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Qualitatively, we found that in many cases there was a histological phenotype known to be associated with either BRAF mutational status or MSI/ dMMR, such as mucinous histology and/or poor differentiation 30,31 .”
From Swarm learning for decentralized artificial intelligence in cancer histopathology (2022) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundBoland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183 · cited 2×
“A reasonable compromise may be to use clinical and histologic features as a guideline in deciding which cases should have additional testing, such as those recommended in the revised Bethesda Guidelines for HNPPC.38 These guidelines state that all CRCs occurring in patients under 50 be tested, and also all CRCs occurr…”
MethodMicrosatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundClues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundIonov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundRibic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
International Histological Classification of Tumours
Weller, R. (1981) · Journal of Clinical Pathology · doi:10.1136/jcp.34.6.692-d · Cited by 2,042
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Research works printed but not linked: 1
- Krishna, 1996, Histopathologic features associated with microsatellite instability in colorectal carcinomas, (Abstract) Gastroenterology, 110, A546
Cited by
Items 101–200 of 285
Lee, S. H., Lee, Y., & Jang, H. (2022) · International Journal of Cancer · doi:10.1002/ijc.34251 · Cited by 27
“21,22 With ongoing studies, the performance of DL-based prediction of MSI status in CRC has greatly improved by expansion of the dataset and enhanced methodology.”
BackgroundTougeron, D., Maby, P., Elie, N., Fauquembergue, É., Pessot, F. L., Cornic, M., Sabourin, J., Michel, P., Frébourg, T., & Latouche, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061001 · Cited by 34
The recent progress of the mechanism and regulation of tumor necrosis in colorectal cancer
Zhang, X., & Chen, L. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1997-z · Cited by 26
Causality and scientific explanation of artificial intelligence systems in biomedicine
Boge, F. J., & Mosig, A. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03033-9 · Cited by 31
“[16], the authors find that activation in MSS is characterized by well-differentiated stroma-rich tissue areas, whereas activation in MSI tissue tends to indicate poorly differentiated tumor glands with immune-infiltrated stroma.”
Ravanini, J. N., Assato, A. K., Wakamatsu, A., & Alves, V. A. F. (2021) · Clinics · doi:10.6061/clinics/2021/e2587 · Cited by 25
“ITL was also assessed in preserved tumors, distant from necrotic areas or from inflammation secondary to previous surgical resection, observed with a 40x microscope objective, and divided into the following three categories: absent, low/ moderate (up to 2 lymphocytes/high-power field), and intense (more than 2 lymphoc…”
Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer
Lee, C., Chow, N.-H., Chen, Y.-L., Ho, C., Yeh, Y., Lin, S.-C., Lin, P., Lin, B., Chu, C., Tsai, H.-W., et al. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153288 · Cited by 30
Roman, R. A., Verdú, M., Calvo, M., Vidal, A., Sanjuán, X., Jimeno, M., Salas, A., Autonell, J., Trias, I., González, M. E., et al. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-0896-6 · Cited by 25
“The study published by Greenson and colleagues [14], even though it does not restrict its series by the patient’s age, finds age under 50 to be the only independent predictor of MSI-H status and includes this parameter as the second most influencing after TIL in the equation of their Pathscore.”
BackgroundResultMelling, N., Simon, R., Mirlacher, M., Izbicki, J. R., Stahl, P., Terracciano, L., Bokemeyer, C., Sauter, G., & Marx, A. H. (2015) · Histopathology · doi:10.1111/his.12726 · Cited by 25
MAP7D2 reduces CD8+ cytotoxic T lymphocyte infiltration through MYH9-HMGB1 axis in colorectal cancer
Wu, Q., Yue, X., Liu, H., Zhu, Y., Ke, H., Yang, X., Yin, S., Li, Z., Zhang, Y., Hu, T., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.001 · Cited by 24
Bodalal, Z., Hong, E. K., Trebeschi, S., Kurilova, I., Landolfi, F., Bogveradze, N., Castagnoli, F., Randon, G., Snæbjörnsson, P., Pietrantonio, F., et al. (2024) · European Radiology Experimental · doi:10.1186/s41747-024-00484-8 · Cited by 25
“Histologically, cancers with MSI are often poorly differentiated or mucinous, contain more prominent lymphocytic in fi ltrate, and show more intratumoral heterogeneity [48, 49].”
BackgroundFujii, S., Kotani, D., Hattori, M., Nishihara, M., Shikanai, T., Hashimoto, J., Hama, Y., Nishino, T., Suzuki, M., Yoshidumi, A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4391 · Cited by 26
Deep learning model to predict Epstein–Barr virus associated gastric cancer in histology
Jeong, Y., Cho, C. E., Kim, J.-E., Lee, J., Kim, N., Jung, W. Y., Sung, J., Kim, J. H., Lee, Y. J., Jung, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22731-x · Cited by 24
Malietzis, G. A., Lee, G. H., Jenkins, J. T., Bernardo, D., Moorghen, M., Knight, S. C., & Al-Hassi, H. O. (2015) · Cell Communication & Adhesion · doi:10.3109/15419061.2015.1036859 · Cited by 25
Lynch syndrome: clinical, pathological, and genetic insights
Schneider, R. A., Schneider, C., Kloor, M., Fürst, A., & Möslein, G. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-0918-8 · Cited by 28
Chen, J., Tang, X.-D., Xiang, D.-B., Dong, X., Peng, F., & Sun, G.-Y. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.7.3427 · Cited by 21
“…early diagnosis is very important for mucinous adenocarcinoma patients, there are many molecular biological differences between mucinous adenocarcinoma and non-mucinous adenocarcinoma, such as MMR protein deficient (Chiang et al., 2010), microsatellite instability (MSI) (Greenson et al., 2009).”
BackgroundCrohn’s Disease–like Reaction Predicts Favorable Prognosis in Colitis-associated Colorectal Cancer
Lewis, B. L., Lin, J., Wu, X., Xie, H., Shen, B., Lai, K., Manilich, E. A., & Liu, X. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31829e13e1 · Cited by 21
“%) had CD.”
BackgroundInfluentialLiddell, C., Droy-Dupré, L., Métairie, S., Airaud, F., Volteau, C., Bezieau, S., LABOISSE, C. L., & Mosnier, J. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.18 · Cited by 21
Soliman, N., Morsi, D. F., & Helmy, N. A. H. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.357 · Cited by 20
“Also, their models included histologic heterogeneity and the type of growth pattern that they are not included in our study [37].”
BackgroundResultIdentification of dirty necrosis in colorectal carcinoma based on multiphoton microscopy
Li, L., Jiang, W., Yang, Y., Chen, Z., Feng, C., Li, H., Guan, G., & Chen, J. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.6.066008 · Cited by 19
“and has become an indispensable factor index as one of the pathologic predictors of MSI in colorectal cancer.(2,3,33,34) MSI is the molecular fingerprint of a deficient MMR system and approximately 15% of CRCs arise in the setting of MSI.”
BackgroundInfluentialMcHugh, K. E., Pai, R. K., Grant, R. C., Gallinger, S., Davison, J., Ma, C., & Pai, R. K. (2025) · Modern Pathology · doi:10.1016/j.modpat.2025.100712 · Cited by 19
Leiby, J. S., Hao, J., Kang, G. H., Park, J. W., & Kim, D. (2022) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc48229.2022.9871553 · Cited by 21
“Pathologic indicators associated with MSI include presence of mucin, poor or undifferentiated histology, and presence of tumor infiltrating lymphocytes (TIL) [11].”
BackgroundInfluentialMurakami, T., Mitomi, H., Yao, T., Saito, T., Shibuya, T., Sakamoto, N., Osada, T., & Watanabe, S. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2234-8 · Cited by 18
Cao, W., Hu, H., Guo, J., Qin, Q., Lian, Y., Li, J., Wu, Q., Chen, J., Wang, X., & Deng, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04023-8 · Cited by 20
“Additionally, it is reported that dMMR/MSI-H tumors tend to have distinct morphological patterns such as poor differentiation, mucinous differentiation, histological heterogeneity, infiltrating lymphocytes, and significant Crohn-like reactions at the tumor frontier [28, 29].”
BackgroundSuzuki, O., Eguchi, H., Chika, N., Sakimoto, T., Ishibashi, K., Kumamoto, K., Tamaru, J., Tachikawa, T., Akagi, K., Arai, T., et al. (2017) · Surgery Today · doi:10.1007/s00595-017-1486-x · Cited by 18
“1), Crohn’s-like lymphatic reaction (≥4 nodular lymphoid aggregation at the advancing edge of the tumor in a low-power (X40) field) [39], medullary growth pattern [40], signet-ring cell differentiation [41], and/or any mucinous components [41], were also checked for and assessed by methods described in the previous re…”
MethodResultSinicrope, F. A., Nelson, G. D., Saberzadeh-Ardestani, B., Segovia, D. I., Graham, R. P., Wu, C. S.-Y., Hagen, C. E., Shivji, S., Savage, P., Buchanan, D. D., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0031 · Cited by 18
KRAS Signaling Pathway Alterations in Microsatellite Unstable Gastrointestinal Cancers
Velho, S., Corso, G., Oliveíra, C., & Seruca, R. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380890-5.00004-1 · Cited by 18
Benchmarking artificial intelligence methods for end-to-end computational pathology
Laleh, N. G., Muti, H. S., Lavinia Loeffler, C. M., Echle, A., Saldanha, O. L., Mahmood, F., Lu, M. Y., Trautwein, C., Langer, R., Dislich, B., et al. (2021) · doi:10.1101/2021.08.09.455633 · Cited by 13
“In contrast, for MSI prediction in colorectal cancer - a task in which classical end-to-end methods outperformed MIL-based methods - the typical MSI-like morphology [19] includes poor differentiation,”
ResultLi, M., Xu, G., Cui, Y., Wang, M., Wang, H. B., Xu, X., Duan, S., Shi, J., & Feng, F. (2023) · Clinical Radiology · doi:10.1016/j.crad.2023.06.012 · Cited by 15
Zhu, J. S., Wu, W., Zhang, Y., Lin, S., Jiang, Y., Liu, R., Wang, X., & Zhang, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.825353 · Cited by 21
“Motivated by the feedback from Grad-CAM and existing studies (9, 58, 59), we focused on these H&E feature characteristics: global and local color features in RGB and HSV channels, the numbers of infiltrating immune cells and tumor cells, the grading of differentiation, and the texture features from tumor cells.”
BackgroundMethodJoost, P., Bendahl, P., Halvarsson, B., Rambech, E., & Nilbert, M. C. (2013) · BMC Clinical Pathology · doi:10.1186/1472-6890-13-33 · Cited by 16
“MsPath [19,23], PREDICT/simplified PREDICT [22], MSI probability score [21] and RERtest6 [20,24] in 200 randomly selected tumors, 20% (n = 40) of which were MMR deficient.”
BackgroundMethodResultInfluentialKRAS Mutations are Associated With Specific Morphologic Features in Colon Cancer
Günal, A., Hui, P., Kılıç, S., Xu, R., Jain, D., Mitchell, K. A., Robert, M. E., & Kenney, B. C. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182703030 · Cited by 16
Microsatellite Instability and Life Style Factors in Sporadic Colorectal Cancer
Atef, N., Alieldin, N., Sherif, G. M., Loay, I., Mahmoud, A. M., & Mohamed, G. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.5.1471 · Cited by 15
“A significant association between smoking cigarettes and colon cancer risk have been reported in only few studies, with associations being null or weak and risk estimates of around 1.3– 1.4 (Nishihara et al., 2015; Jass et al., 2007; Guastadisegni et al., 2010; Chen et al.,2015).”
BackgroundInfluentialGustav, M., van Treeck, M., Reitsam, N. G., Carrero, Z. I., Loeffler, C. M. L., Meneghetti, A. R., Märkl, B., Boardman, L. A., French, A. J., Goode, E. L., et al. (2025) · The Lancet Digital Health · doi:10.1016/j.landig.2025.100891 · Cited by 23
“Additional metrics and prediction score distributions (figures 1D, 3B, 4; appendix pp 20–25, 34–35) quantified model certainty, with prediction scores ranging from 0 ⋅ 00 (wild type, low) to 1 ⋅ 00 (mutated, high).”
Bell, P. D., & Pai, R. K. (2022) · Histopathology · doi:10.1111/his.14713 · Cited by 16
“Histologically, MSI-high (MSI-H)/mismatch repair-deficient (dMMR) colorectal carcinomas exhibit a prominent immune response which may manifest as an increase in intraepithelial lymphocytes, intra-/peritumoral lymphocytes and/or a prominent Crohn’s-like reaction.(37,48) More specifically, when compared to microsatellit…”
BackgroundZhao, Y., Wang, W., Ji, Y., Guo, Y., Duan, J., Liu, X., Yan, D., Liang, D., Li, W., Zhang, Z., et al. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.01.009 · Cited by 16
Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms
Bellizzi, A. M. (2013) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2013.11.001 · Cited by 14
Fu, L., Sheng, J., Li, X., Jin, P., Mu, H., Han, M. Y., Huang, J.-S., Sun, Z., Li, A., Wu, Z., et al. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0130-z · Cited by 14
“Mutations in any one of these genes may lead to loss of the corresponding protein(s) and, concomitantly, to loss of specific DNA mismatch repair function(s), resulting in microsatellite instability (MSI) and, ultimately, tumor development [5, 6].”
Dai, N.-N., Hu, M.-Y., Wang, J., Dai, Z.-H., Xu, L., & Ye, T. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04108-x · Cited by 17
“Previous studies have classified TLS into early TLS (E-TLS) [23], primary follicle-like TLS (PFL-TLS) [24], and secondary follicle-like TLS (SFL-TLS) [25].”
Azevedo, C. M., Xie, B., Gunn, W. G., Peralta, R. M., Dantas, C. S., Fernandes-Mendes, H., Joshi, S. K., Dean, V. G., Almeida, P., Wilfahrt, D. N., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-0313 · Cited by 19
Low MicroRNA-19b Expression Shows a Promising Clinical Impact in Locally Advanced Rectal Cancer
Rubio, J., Cristóbal, I., Santos, A., Caramés, C., Luque, M., Sanz-Álvarez, M., Zazo, S., Madoz‐Gúrpide, J., Rojo, F., & García‐Foncillas, J. (2021) · Cancers · doi:10.3390/cancers13061456 · Cited by 13
“According to clinical guidelines, every regression grade was compared with the primary tumor [39].”
MethodXu, K., Song, X., Chen, Z., Qin, C., & He, Y. (2014) · Oncology Letters · doi:10.3892/ol.2014.2236 · Cited by 13
“Compared with microsatellite stable (MSS) tumors, sporadic MSI tumors exhibit recognizable clinicopathological features, including the absence of necrosis, the presence of a Crohn's-like reactions, a right-sided location, a lower pathological stage and an improved prognosis (2-4).”
BackgroundZhao, M., Yao, S., Li, Z., Wu, L., Xu, Z., Pan, X., Lin, H., Xu, Y., Yang, S., Zhang, S., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03079-z · Cited by 14
Gong, Q. S., Zhang, H.-H., Sun, S., Ge, W., Li, Y., Zhu, Y., & Li, L. (2018) · Oncology Letters · doi:10.3892/ol.2018.8192 · Cited by 14
“A total of 16 cases were excluded, which included FAP (n=1), HNPCC (n=4), death from cardiopulmonary complication (n=1), neuroendocrine neoplasm (n=1), recurrence of colorectal carcinoma (n=1) and neo-adjuvant chemotherapy (n=8).”
InfluentialSacdalan, D. L., Garcia, R. L., Diwa, M. H., & Sacdalan, D. B. (2021) · Cancer Management and Research · doi:10.2147/cmar.s286618 · Cited by 13
Paulose, R. R., Ail, D. A., Biradar, S., Vasudevan, A., & Sundaram, K. R. (2019) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_365_18 · Cited by 12
“Tumor infiltrating lymphocytes (TIL) and peritumoral (Crohns-like) lymphocytic response (CLR) were graded according to CAP guidelines as: None/mild to moderate/ marked[13] 5.”
MethodImmunohistology of the Gastrointestinal Tract
Krasinskas, A. M., & Goldsmith, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5766-6.00018-2 · Cited by 16
Prediction of molecular subtypes for endometrial cancer based on hierarchical foundation model
Cui, H., Guo, Q., Xu, J., Wu, X., Cai, C., Jiao, Y., Ming, W., Wen, H., & Wang, X. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf059 · Cited by 13
“It has been shown that specific morphological patterns presented by tissues are associated with certain genetic alterations among different cancers (Greenson et al. 2009, Ninomiya et al. 2009, Pai et al. 2012).”
Fu, X., Huang, J., Junling, Z., Fan, X., Wang, C., Deng, W., Tan, X., Chen, Z., Cai, Y., Lin, H., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34946 · Cited by 11
Self-citationFaa, G., Coghe, F., Pretta, A., Castagnola, M., Eyken, P. V., Saba, L., Scartozzi, M., & Fraschini, M. (2024) · Diagnostics · doi:10.3390/diagnostics14151605 · Cited by 16
Yilmaz, O. H., Westerhoff, M. A., Panarelli, N. C., Hart, J. A. L., Groisman, G. M., Ruz‐Caracuel, I., Loughrey, M. B., Matsukuma, K. E., Lee, S., Yilmaz, Ö. H., et al. (2023) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000002141 · Cited by 10
“22 The diagnoses rendered in the majority of cases within our cohort referred/alluded to the neoplasm as ’ dome ’ or GALT-like.”
BackgroundPark, J., Chung, Y. R., & Nose, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-16283-3 · Cited by 10
Yang, S., Hu, H., Hu, Y.-F., Dai, Y.-S., Zou, R.-Q., Lv, T., & Li, F. (2023) · Cancer Medicine · doi:10.1002/cam4.5742 · Cited by 10
Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer
Tsai, Y.-Y., Qu, C., Bonner, J. D., Pamplona, R. S., Lindsey, S. S., Melas, M., McDonnell, K., Idos, G., Walker, C., Tsang, K. K., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1268117 · Cited by 13
Self-citationDroy-Dupré, L., Bossard, C., Volteau, C., Bezieau, S., LABOISSE, C. L., & Mosnier, J. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1724-9 · Cited by 10
Piredda, M. L., Ammendola, S., Sciammarella, C., Turri, G., Bagante, F., Fassan, M., Mafficini, A., Mombello, A., Cataldi, S., Paolino, G., et al. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153519 · Cited by 12
Jinling, S., Li, Z., Yang, L., Wei, M., Yang, Z., & Wang, X. (2022) · BMC Cancer · doi:10.1186/s12885-022-09871-z · Cited by 11
“MSI-H tumor have high level of CD3+ and CD8+ TILs and a prominent inflammatory reaction (Crohn-like reaction) at the advancing edge of the tumor [28, 33].”
BackgroundWang, W., Shi, W., Nie, C., Xing, W., Yang, H., Li, F., Liu, J., Tian, G., Wang, B., & Yang, J. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.107608 · Cited by 10
Mirchev, M. B., Kahl, P., Friedrichs, N., Kotzev, I. A., & Buettner, R. (2010) · Folia Medica · doi:10.2478/v10153-010-0043-9 · Cited by 8
Arshita, N., Lestari, R. V., Hutajulu, S. H., Ghozali, A., & Paramita, D. K. (2018) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2018.19.11.3147 · Cited by 10
“…of Cancer Prevention, Vol 19 3151 DOI:10.31557/APJCP.2018.19.11.3147 The Association of Clinicopathological Features and MSH2 and/or MSH6 MSI in Patients with CRC cases that have a tendency to have MSI-H usually involve the poor differentiated tumor (Greenson et al., 2009; Xiao et al., 2013).”
BackgroundInfluentialBrazowski, E., Rozen, P., Pel, S., Samuel, Z., Solar, I., & Rosner, G. (2012) · Familial Cancer · doi:10.1007/s10689-012-9508-8 · Cited by 8
“TILs tumor-infiltrating lymphocytes, HPF high-powered field a Reference [7] b Reference [8] c One or the other scored by PathScore”
BackgroundMethodInfluentialHow to Manage the Patient with Early-Age-of-Onset (<50 years) Colorectal Cancer?
Liang, J., & Church, J. M. (2010) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2010.07.007 · Cited by 8
Author Correction: Pan-cancer image-based detection of clinically actionable genetic alterations
Kather, J. N., Heij, L. R., Grabsch, H. I., Loeffler, C. M. L., Echle, A., Muti, H. S., Krause, J., Niehues, J., Sommer, K. A. J., Bankhead, P., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00149-6 · Cited by 10
Huang, J., Xu, L., Cai, Y., Tan, X., Lin, H., Chen, Z., Wang, C., Deng, W., & Fu, X. (2025) · BMC Cancer · doi:10.1186/s12885-025-14484-3 · Cited by 12
Gheorghe, D., Staden, R. S., Pogăcean, F., & Pruneanu, S. M. (2022) · Chemosensors · doi:10.3390/chemosensors10100380 · Cited by 7
Cannarozzi, A. L., Biscaglia, G., Parente, P., Latiano, T. P., Gentile, A., Ciardiello, D., Massimino, L., Brina, A. L. P. D., Guerra, M., Tavano, F., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104694 · Cited by 8
Omura, Y., Toiyama, Y., Okugawa, Y., Yamamoto, A., Yin, C., Kusunoki, K., Kusunoki, Y., Shigemori, T., Ide, S., Kitajima, T., et al. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07709-w · Cited by 7
Prediction Model for Gastric Cancer With DNA Mismatch Repair Deficiency
Suzuki, O., Yamaguchi, T., Fukuchi, M., Mochiki, E., Arai, T., Akagi, K., & Ishida, H. (2021) · Anticancer Research · doi:10.21873/anticanres.14851 · Cited by 8
García‐Solano, J., Conesa‐Zamora, P., Carbonell, P., Trujillo‐Santos, J., Torres‐Moreno, D., Rodríguez-Braun, E., Vicente‐Ortega, V., & Pérez‐Guillermo, M. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.07.020 · Cited by 7
“The predictor histologic features proposed by Greenson et al [7] are quite similar to those of MsPath [1], although the former investigators added 2 new parameters to their MSI probability score, that is, lack of dirty necrosis and well or poor tumor differentiation as independent predictors of MSI-H; both pathologic…”
BackgroundLeo, E. K. D., Shah, C., Grajo, J. R., Liu, X., & Parekh, H. D. (2021) · Cureus · doi:10.7759/cureus.12899 · Cited by 7
“Histopathologically, MMR deficient tumors are characterized by having increased tumor-infiltrating lymphocytes and prominent inflammatory reactions [7, 8].”
BackgroundTeixeira, S. A., Luzzi, M. D. C., Martin, A. C. B. M., Duarte, T. T., Leal, M. D. O., Teixeira, G. R., Reis, M. T., Junior, C. R. D. A., Santos, K., Melendez, M. E., et al. (2022) · Veterinary Sciences · doi:10.3390/vetsci9110636 · Cited by 7
Malignant Epithelial Neoplasms of the Large Bowel
Walsh, S. V., & Carey, F. A. (2012) · Wiley eBooks · doi:10.1002/9781118399668.ch38 · Cited by 8
Pollett, A. F. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.008 · Cited by 7
H&E-based MSI/MMR testing with AI in colorectal cancer: a multi-centred blinded evaluation
Bass, C., Ntelemis, F., Schmidt, J., Wolf, S., Geraldes, A., Mehrotra, D. G., Singhal, S., Kumar, N., Marcia, A., Bennett, N., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02218-5 · Cited by 8
“Tumour stage variedacrosscohorts,withstageIIandIIIbeingthemostcommon.”
Jiang, Z., Yan, L., Deng, S., Gu, J., Qin, L., Mao, F., Xue, Y., Cai, W., Nie, X., Liu, H., et al. (2023) · Disease Markers · doi:10.1155/2023/5178750 · Cited by 8
Li, Y., Xiong, X., Liu, X., Wu, Y., Li, X., Liu, B., Lin, B., Yu, L., & Xu, B. (2024) · PeerJ · doi:10.7717/peerj.18098 · Cited by 9
“Hematoxylin and eosin (H&E)-stained slides contain enormous information about molecular features, cell morphology, and tissue structure, aiding in the detection of changes in molecular biomarkers ( Greenson et al., 2009 ; Shia et al., 2017 ).”
BackgroundNasr, E., Al-Hamid, Z., Younan, M. H., Omran, M., Sarsam, M., & Abdellatif, M. (2025) · Cureus · doi:10.7759/cureus.95178 · Cited by 7
“To address these limitations, researchers have developed AU methods that infer MSI status directly from whole-slide images (WSIs) across multiple cancer types [19-21].”
Immunohistochemistry in Gastroenterohepatopancreatobiliary Epithelial Neoplasia
Bellizzi, A. M. (2013) · Surgical pathology clinics · doi:10.1016/j.path.2013.06.003 · Cited by 7
Recording of family history is associated with colorectal cancer stage
Kessels, K., de Groot, N. L., Fidder, H. H., Timmer, R., Stolk, M. F. J., Offerhaus, G. J. A., & Siersema, P. D. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835c45a3 · Cited by 6
Molecular characteristics of young‐onset colorectal cancer in Vietnamese patients
Do, M. D., Nguyen, T. H., Le, K. T., Le, L. H. G., Bắc, N. H., Le, K. T., Doan, T. P. T., Ho, C. Q., Nguyen, H., Tran, T. D., et al. (2022) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13749 · Cited by 6
“Time from symptom to diagnosis (day), (Median - min, max) 60 (2-720) 30 (0-360) 75 (5-360) 60 (2-72)”
Adherence to Microsatellite Instability Testing in Young-Onset Colorectal Cancer Patients
Kessels, K., Fidder, H. H., de Groot, N. L., Letteboer, T. G. W., Timmer, R., van Dalen, T., Consten, E. C. J., Offerhaus, G. J. A., & Siersema, P. D. (2013) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e31828b6617 · Cited by 6
“02a Alive 236 (70) 101 (78) 135 (66) Deceased 97 (29) 28 (22) 69 (34) Lost to FU 2 (1) 1 (1) 1 (0) AJCC staging 0.”
Na, W., Lee, I. J., Koh, I., Kwon, M., Song, Y. S., & Lee, S. H. (2023) · Medicine · doi:10.1097/md.0000000000033647 · Cited by 7
“[42,43] These findings thus indicate that tube-forming properties, which may be mediated by the EDAR or SHH protein, [44,45] are important functional differences between MSI colon and endometrial cancers, of which, EDAR has been established to promote colorectal carcinogenesis via the Wnt/ β…”
Marković, S. Z., Antic, J. A., Dragicevic, N., Hamelin, R., & Krivokapić, Z. (2011) · Journal of Molecular Histology · doi:10.1007/s10735-011-9387-6 · Cited by 6
“In this study of Serbian patients, primary tumor localization and presence of mucinous component are in accordance with previous publications (Kazama et al. 2007, 2008; Greenson et al. 2009; Jenkins et al. 2007).”
BackgroundResultMulti-cancer analysis of histopathologic MSI screening based on digital histology image
Lee, J., Kim, C. Y., Lee, S., & Chung, J.-H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332034 · Cited by 6
“For example, MSI-H colorectal cancer histopathologic images present more tumor-infiltrating lymphocytes, mucinous differentiation, medullary-like morphology, or lack of necrosis [11,12].”
Hu, T., Luan, H., Yan, R., Hu, J., Yang, K., Han, X., Liu, W., He, J., Duan, X., Li, R., et al. (2024) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm62325.2024.10822101 · Cited by 5
“…pathological characteristics that necessitate observation at various magnifications: high magnification for cellular details such as tumor cells and lymphocytes, and lower magnifications for examining the tumor’s edges and its spatial relationship with surrounding cells [12], [20], [21].”
Clinical and morphological portrait of tumors with microsatellite instability
Musaelyan, A. A., Назаров, В. Д., Budnikova, A. S., Lapin, S. V., Vorobyev, S. L., Emanuel, V. L., Захаренко, А. А., & Orlov, S. V. (2021) · Advances in molecular oncology · doi:10.17650/2313-805x-2021-8-2-52-59 · Cited by 5
Características histopatológicas del carcinoma colorrectal con inestabilidad microsatelital (IMS)
Ayala, R. L. B., Carvajalino, L. F. P., Rodríguez, O. G., Nieto, J. F. P., López-Correa, P., & Medina, R. P. (2020) · Revista Repertorio de Medicina y Cirugía · doi:10.31260/repertmedcir.v29.n1.2020.172 · Cited by 6
Santos, A., Cristóbal, I., Rubio, J., Caramés, C., Luque, M., Sanz-Álvarez, M., Morales-Gallego, M., Madoz‐Gúrpide, J., Rojo, F., & García‐Foncillas, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042203 · Cited by 5
“According to clinical guidelines, every regression grade was compared with the primary tumor [53].”
MethodWu, S., Qian, X., Yu, X., Sheng, H., & Lü, B. (2012) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3182434174 · Cited by 4
A Model for Predicting DNA Mismatch Repair-deficient Colorectal Cancer
Chikatani, K., Chika, N., Suzuki, O., Sakimoto, T., Ishibashi, K., Eguchi, H., Okazaki, Y., & Ishida, H. (2020) · Anticancer Research · doi:10.21873/anticanres.14441 · Cited by 4
Liu, G., Lin, J., Xie, H., Shen, B., Stocchi, L., & Liu, X. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1052094 · Cited by 4
Pathological evaluation of colorectal cancer specimens: advanced and early lesions.
Resch, A., Schneider, N. I., & Langner, C. (2015) · PubMed · Cited by 6
Başak, F., Kaya, M., Şişik, A., Hasbahçecı, M., Baş, G., Alımoğlu, O., Topal, C. S., & Kır, G. (2017) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.174558 · Cited by 4
Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer
Vlahović, I., Rajc, J., Švagelj, I., Šolić, K., & Švagelj, D. (2023) · Pathology & Oncology Research · doi:10.3389/pore.2023.1610908 · Cited by 4
“published that treatment of dMMR rectal cancer with anti-PD-1 monoclonal antibody Dostarlimab for 6 months resulted in complete response in all of the 12 patients included in study [41].”
BackgroundOverview of Predictive Biomarkers and Integration of IHC into Molecular Pathology
Chen, Z. E., & Lin, F. (2015) · Springer eBooks · doi:10.1007/978-1-4939-1578-1_9 · Cited by 4
Neoplastic diseases of the small and large intestines
Agoston, A. T., & Odze, R. D. (2015) · Cambridge University Press eBooks · doi:10.1017/9781139137201.028 · Cited by 4
Clinical and pathological tools for identifying microsatellite instability in colorectal cancer
Krivokapić, Z., Marković, S. Z., Antic, J. A., Dimitrijević, I., Bojic, D., Svorcan, P., Jojic, N. Z., & Damjanovic, S. S. (2012) · Croatian Medical Journal · doi:10.3325/cmj.2012.53.328 · Cited by 4
Pathology and Molecular Pathology of Colorectal Cancer
Poulin, E. J., Shen, J., Gierut, J. J., & Haigis, K. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_22 · Cited by 5
Rightward shift in colorectal cancer: experience in 1101 patients
RIO, P. D., Rossini, M., Giuffrida, M., Cozzani, F., Guarnieri, E., & Dell’Abate, P. (2020) · Minerva Surgery · doi:10.23736/s0026-4733.20.08263-2 · Cited by 4
Baumann, E., Schäfer, L., Meeuwsen, F. C., Kirsch, R., Nagtegaal, I. D., Berger, M. D., Dawson, H., & Zlobec, I. (2025) · Modern Pathology · doi:10.1016/j.modpat.2025.100932 · Cited by 5
Jang, M., Hong, Y., Hong, S., & Kim, E. K. (2025) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2024-0350-oa · Cited by 3
Metadata
- Authors
- Greenson, J. K., Huang, S.-C., Herron, C., Moreno, V., Bonner, J. D., Tomsho, L. P., Ben-Izhak, O., Cohen, H. I., Trougouboff, P., Bejhar, J., Sova, Y., Pinchev, M., Rennert, G., & Gruber, S. B.
- Affiliations
- Michigan Medicine (US)
- Institut Català d'Oncologia (ES)
- Western Galilee Hospital (IL)
- Emek Medical Center (IL)
- Bnai Zion Medical Center (IL)
- Corresponding author
- Greenson, Joel K.
- Sova, Yanina
- Venue
- American Journal of Surgical Pathology
- Published
- 2009-01
- Volume
- 33
- Issue
- 1
- Pages
- 126-133
- ISSN
- 0147-5185 (ISSN-L)
- PMC
- PMC3500028
- OpenAlex
- W2055732173
- Cited by
- 286
- References
- 43
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 20 · 2023: 30 · 2022: 31 · 2021: 22 · 2020: 20 · 2019: 16 · 2018: 8 · 2017: 11 · 2016: 7 · 2015: 15 · 2014: 11 · 2013: 18 · 2012: 19
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The American Journal of Surgical Pathology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA081488)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- microsatellite instability, MSI-H colorectal cancer, Lynch syndrome, tumor-infiltrating lymphocytes, mucinous differentiation, tumor location, tumor differentiation, logistic regression prediction model
- MeSH terms
- Adenocarcinoma, Adult, Age Factors, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Regression Analysis, ROC Curve, Sensitivity and Specificity, Colorectal Neoplasms, Lymphocytes, Tumor-Infiltrating, Area Under Curve, Reverse Transcriptase Polymerase Chain Reaction, Microsatellite Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.